Chronic drug shortages impact patient care across the United States. Our mission is to provide quality generic medicines that are available and affordable to everyone.
Member hospital teams and their patients now have reliable access to over 50 Civica medicines, including those used to help fight COVID-19.
The new facility, part of a partnership with Virginia-based Phlow Corp., will employ more than 180 people and will help ensure a safe, stable, and affordable supply of essential generic medicines for U.S. patients. Civica will produce sterile injectable medications used in hospitals for COVID-19 patient care, emergency room and intensive-care unit treatments, surgeries,...
We are so proud of Civica's Chief Commercial Officer, Heather Wall, for her recognition as one of Utah Business Magazine's "2020 CXO's of the Year." Heather has been instrumental in the design of Civica from concept to today. “Heather is a force of nature - she inspires all of us with her energy, expertise...
Launched in 2018 as a nonprofit generic drug company to address the problem of chronic drug shortages, Civica Rx (Civica, Inc) has proven to be a viable industry player, ensuring stable and predictable supplies of over 20 essential generic drugs so far, and generating millions of dollars in savings for hospitals. The brainchild of...
Over the past two decades, shortages of generic, injectable drugs critical to the lifesaving work of hospitals in the United States have become commonplace. These drug shortages are so ubiquitous that hospitals and health care systems now maintain permanent drug shortage response teams that seek alternatives to unavailable drugs.
As a result, time that hospital pharmacists, technicians, nurses and others would prefer to spend caring for patients is spent ensuring that the patients who most need short-supply drugs get whatever supply is available.
Civica was created to reduce and prevent drug shortages and the price spikes that can accompany them. Its mission is to make quality generic medicines accessible and affordable to everyone.